NORTHERN OHIO FOUNDATION
|
|
- Estella Rodgers
- 5 years ago
- Views:
Transcription
1 NORTHERN OHIO FOOT & ANKLE FOUNDATION The Northern Ohio Foot and Ankle Journal Treatment of Acute Charcot by Nicole Nicolosi, DPM 1 Official Publication of the NOFA Foundation The Northern Ohio Foot and Ankle Journal 1 (1): 1 Abstract: The acute stage of Charcot is classified under Eichenholtz s classification as stage I. The gold standard for treatment of acute Charcot is offloading, usually non-weight-bearing. Discrepancy in the literature exists about the method of total contact cast application, frequency of cast changes, duration of cast therapy, the use of removable versus non-removable casts, and whether the patient should remain non-weight bearing. The literature trend is to allow full weight-bearing in a total contact cast for forefoot or midfoot Charcot and restrict to nonweight-bearing in a device for rearfoot Charcot. The contralateral foot is placed in an orthosis or offloading device to avoid bilateral Charcot development. Pharmacological management of acute Charcot is currently unsupported. Key words: Diabetes, Total Contact Casting, Removable cast walker, Bisphosphonates, iatrogenic cast complications Accepted: October, 2014 Published: October, 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License. It permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Northern Ohio Foot and Ankle Foundation Journal. ( All rights reserved. The acute stage of Charcot is classified under Eichenholtz s classification as stage I. 1 During this stage, which is approximately 2-6 months in duration, the patient s foot presents with calor, edema, and erythema. 2 Radiographic destructive changes develop at the end of this stage and consist of peri-articular fracture and joint subluxation. 2,3 Offloading The gold standard of acute Charcot treatment is the patient should be offloaded, usually non-weightbearing in a total contact cast (TCC), until the acute stage has resolved. 3,4 Offloading is necessary in Address correspondence to: mhardy@healthspan.org. Department of Foot and Ankle Surgery, HealthSpan Physicians 1 Resident, Department of Foot and Ankle Surgery, HealthSpan Physicians Group, Cleveland, OH Figure 1 image courtesy of Dr. Georgeanne Botek 7, DPM. Figure 3 taken from Trepman E. Donnelly P. Patellar Tendon-Bracing, Patten- Bottom Caliper Suspension Orthosis in Active Charcot Arthropathy: Crutch- Free Ambulation with No Weight Bear in the Foot. Foot & Ankle International (4): patients with peripheral neuropathy as an insensate foot hinders the body s innate response to offload a painful foot. Offloading reduces weight bearing forces during the inflammatory and destructive stage and is continued until the foot stabilizes and osseous structures are able to withstand the stresses of weightbearing without deformity formation. 2,3,5 The goal of acute Charcot treatment is to allow the foot to stabilize in a position of minimal deformity which can be accommodated in a shoe or appropriate orthosis. 2 The effect of offloading was documented by Piaggesi et al in 2003 which revealed offloading results in the reduction of inflammatory and reactive components and accelerates wound healing. 4 A delay in treatment results in irreversible pedal deformity secondary to the patient walking on an insensate foot. 6 An example of this mechanism is weight-bearing induced Chopart s joint fragmentation and dislocation resulting in mid-foot collapse or a
2 rocker-bottom foot. 6 Such pedal deformities increase the patient s risk of ulceration which thereby increases the risk of amputation and subsequent mortality of the patient. 6 In a study by Van Baal et al in 2010, patients with acute Charcot foot or neuropathic foot ulcers had a 5-year mortality rate of 40%. 6 The Northern Ohio Foot & Ankle Foundation Journal prominences, such as the malleoli and tibial crest, for protection from the cast. If an ulceration is present, a dry sterile dressing is applied or else a cast windowing technique can be utilized for more frequent dressing changes. Total Contact Casting Numerous studies have documented the efficacy of total contact casting. Total contact casting increases the pedal contact surface area, redistributes the total pressure over this larger area, and avoids excessive concentration of pressure over prominences. A weight bearing TCC offloads the forefoot and midfoot by 80% and this pressure is transferred to the hind-foot. 5 Therefore it is not recommended that a weight-bearing TCC be used to treat hind-foot Charcot. 5 One study revealed that a TCC increases the load under the heel approximately 37%. 7 Other limitations to TCC are its application is consuming, material availability dependent, and it requires clinical attention and skill to avoid severe iatrogenic complications. In addition, discrepancy in the literature exists about the method of application, frequency of cast changes, duration of cast therapy, the use of removable versus non-removable casts, and whether the patient should remain non-weight bearing. 10 Method of TCC Application There is currently no universally accepted method of application and there are a variety of different modifications. The snug fit of a total contact cast minimizes the repetitive microtrauma and shear forces which can result in ulceration formation. Cotton or lamb s wool is placed in between the toes to avoid such irritation. A stockinette followed by webril is then applied. Sifoam can be used to cover the toes and any ulcer site since it has been shown to reduce pressure by 50%. 8 One-eighth inch felt is used to cover bony Figure 1: Bilateral Total Contact casting with felt applied to areas of bony prominence, sifoam covering the toes, and webril. Cost Although the materials required for TCC application are numerous and costly, TCC is cost effective. Myerson et al revealed that the average total cost for outpatient TCC treatment was approximately equivalent to the cost of a single day as an inpatient. 9 Frequency of TCC Changing Generally, casts should be checked regularly and replaced as necessary. 10 A review of the literature
3 Volume 1, No. 1, October 2014 reveals that the first cast should be changed within the first 3 days and be performed either weekly or biweekly thereafter to allow for the decrease in edema and the continuance of a snug fit cast.2,3,13 The patient should be instructed to inspect their cast daily for cracks and immediately report any signs of complications.10 The patient should also monitor their blood glucose and body temperature daily to alert their physician of possible infection.10 Nicolosi there was a strong correlation between clinical and MRI findings in the healing of bony lesions.10 Duration of Casting The duration of casting has been cited in the literature to range from 5.8 weeks to 12 months, with approximately 6 months on average.3,10,13,14 Insufficient duration can result in deformity or deterioration of an existing foot deformity.14 The response to therapy, and thus duration determination, is identified clinically using visual monitoring of erythema and edema reduction, and by measuring temperature differences using infrared thermometry Patients should be offloaded until signs of inflammation have resolved, serial radiographs reveal evidence of osseous consolidation, and the affected foot temperature is within 2 degrees Celsius of the contralateral foot at 2 consecutive visits.5,14,15 Milne et al states that temperatures should be assessed approximately 15 minutes after the cast and footwear is removed.13 Absolute skin temperatures have been cited to range from degrees Celsius in the acute Charcot foot and about degrees Celsius in the non-charcot foot.14 Although, McCrory et al in 1998 stated skin temperature was unreliable in determining treatment duration and recommended a fixed period of total contact casting of 6 months.14 There is some evidence of the use of ancillary imaging to determine phase resolution. In one study by McGill et al in 2000, there was a strong correlation between temperature difference and the bone scanning ratio of isotope uptake of the effected and non-affected foot.10 Zampa et al in 2011 revealed that Figure 2: Left Charcot neuroarthropathy in an African American patient. Note increased edema when compared to contralateral limb. Weight-bearing versus Non-Weight-bearing casts There is insufficient evidence to support that either weight-bearing status is superior to the other.10 The reasoning behind non-weight-bearing is to prevent the progression of osseous deformity in the insensate foot. Non-weight-bearing prevents the foot from continuing to fracture and the propensity of inflammation during ambulation.12 However, patients tend to be non-compliant with complete non-weight-bearing for extended periods of time.2 McDermott revealed that patients bear weight because of decreased sensation (patients are unsure if they are placing weight on the foot or not), frank non-compliance, and deficiencies in health, function, proprioception and balance which result in the inability to use assistive devices such as a walker or crutches.2 Pinzur et al conducted a prospective study on 9 Charcot patients treated with biweekly weight-bearing TCC.3 Patients were casted for an average of 5.8 weeks (4-10 weeks) and were transitioned to specialized shoegear when they were deemed stable, which was at an average of 12 weeks. They found a
4 TCC reliably arrested the short term destructive disease process and that weight-bearing in a TCC did not increase morbidity. They concluded that weightbearing in a TCC allowed all of their subjects to transition to prescription footwear without subsequent morbidity at 5 months. De Souza also conducted a prospective 18 year study on 27 patients with early Charcot to evaluate the results of weight-bearing in TCC. 2 Lesions were Brodsky type I-III, average follow-up duration was 5.5 years and casts were changed at weekly intervals until disease resolution. The average period of immobilization was 14 weeks with a range of 4-20 weeks. 2 A Brodsky type IIIA lesion was found to have a longer duration of casting (16 weeks) than type I and type II lesions, which were casted for averages of 9 and 13 weeks, respectively. 2 Only 1 patient (Brodsky type I lesion) had progression of deformity while weight-bearing in a total contact cast. 2 None of the patients developed ulcerations in the total contact casts but 10/34 feet developed ulcerations after they were put into orthosis. 2 They concluded that weightbearing in a TCC did not result in increased deformity or increased risk of ulceration and did not prolong time of immobilization. There are several other advantages of weight-bearing in a TCC. Ambulating while in a TCC has been associated with increased venous return and decreased local edema, and thus improved microcirculation. 8 Another advantage is the avoidance of bilateral Charcot development. Bilateral Charcot Sanders and Frykberg in 2000 stated that development of contralateral Charcot has been reported in up to 40% of patients treated with nonweight-bearing secondary to increased mechanical forces in the opposite foot. 10 The literature reveals that even a three-point gait using crutch offloading may still increase the load to the contralateral foot enough for Charcot development. 13 Clohisy and The Northern Ohio Foot & Ankle Foundation Journal Thompson recommended that prophylactic immbolization be performed on the contralateral extremity in a protective cast or orthosis in order to prevent the development of Charcot on the contralateral limb. 2 Removable versus Non-Removable Casts Although a TCC is well accepted as the gold standard therapy, there is no randomized controlled study revealing the superiority of one device in the treatment of Charcot. 10 In a study by Game et al in 2012, they revealed that total contact casting was used as for initial Charcot treatment in the United States in only 49% of cases. 10 This same UK study demonstrated that non-removable casts had a superior outcome and a shorter time to resolution (9 months) than removable casts (12 months) in the treatment of Charcot. 10,14 Boulton in 2004 conducted a randomized controlled trial comparing TCC with other offloading devices and healing of diabetic foot ulcers and found that healing was most rapid in patients treated with a TCC. 4 Removal cast walkers redistribute pressure in a similar manner to TCC but the most likely reason why TCC therapy has better outcome is because of noncompliance issues. A study by Armstrong et al in 2003 consisted of recording total activity with a waistworn computerized accelerometer (pedometer) and correlated activity with a hidden pedometer in the removable cast walker (RCW). 15 This study revealed that only 28% of daily activity was performed while wearing the RCW. 15 The instant total contact cast (itcc) was made to curbside RCW compliance issues. The itcc is constructed by wrapping 2 bands of plaster over the RCW making the device non-removable. Advantages of an itcc include that it s inexpensive, quick and easy to apply, generally more acceptable to the patient, and no specialist cast clinician is needed. Christensen et al in 2012 conducted a retrospective 5 year study on 56 diabetic patients with acute Charcot
5 on the duration and recurrence rate of patients treated with non-weight-bearing removable walker with the assistance of crutches. 14 Average offloading duration was 141 +/- 21 days, which is 20 weeks or approximately 5 months. Seven patients (12%) were re-casted after recurrence within an average of 69 days (11 weeks or 3 months). 14 The re-casting duration was 79 +/- 44 days. There was no significant difference between duration of primary offloading and re-casting offloading, 142 and 134 days respectively. 14 The authors concluded that less restrictive off-loading in a removable cast is a safe treatment for the treatment of Charcot. 14 Nicolosi They advised that patients should be informed of potential complications and risks before cast application. TCC Complications Total contact casting can induce unnatural stress patterns which result in ulceration and amputation. 5,14 Casting may also increase instability and affect proprioception, resulting in an increased fall and fracture risk. 5 It also can result in a reduction in muscle tone, bone density, and muscle tone and strength. 5 However, Pakarinen et al in 2013 reported that the bone mineral density in the proximal femur and lumbar spine is only slightly decreased or equivalent to a control population after immobilization treatment for Charcot. 16 Guyton in 2005 performed a prospective study on 70 peripheral neuropathic patients who completed a series of 398 walking total contact casts during a 28 month period. 17 The overall complication rate was 5.52%, and 30% of patients had one complication during their treatment course. Complications occurred in 22 casts: 6 new pretibial ulcers, 6 new mid-foot ulcers, 4 forefoot or toe ulcers, 5 hind-foot ulcers, and 1 malleolar ulcer. No previous ulcers were made worse and 100% new ulcers healed within 3 weeks (often with TCC). One cast led to a proximal inter-phalangeal joint ulceration which led to digital amputation. They concluded that a frequently changed TCC is a safe modality for the offloading and immobilization of the neuropathic foot. Complications tend to be prevalent but minor and reversible, even in an experienced clinician s hands. Figure 3: Patellar Tendon-Bracing and Patten bottom caliper suspension orthosis. Note the foot is completely suspended above the ground. Patellar Tendon-Bracing and Patten Bottom Caliper Suspension Orthosis Trepman and Donnelly in 2002 conducted a study on patellar tendon-bracing and patten-bottom caliper suspension orthosis in the treatment of Eichenholtz stage I Charcot. 18 The patten-bottom caliper orthosis is a device that results in 100% non-weight-bearing to the foot without the use of crutches. The modified device results in foot suspension above the floor by a splint and weight-bearing is achieved with a supra-
6 patellar strap. 18 Two of six patients in their study resulted in symptom resolution, in 7 months and 13 months duration. The brace was seldom used in 4 of the 6 patients because of general debility, discomfort using the lift, difficulty with balance, and poor compliance. The most common complaint was improper fitting which resulting in the orthosis sliding down or pistoning on the leg. Minor problems were experienced including superficial skin breakdown along the pretibial area. They stated that patient selection was important for patient benefit since the patients who most benefited were those that were functionally active and motivated. Anti-Resorptive Therapies Various pharmacological treatments aim to correct the imbalance between bone resorption and bone formation. 10 However there is no proven pharmacological treatment currently available for Charcot treatment. 19 Since there is evidence that the acute stage of Charcot is associated with increased osteoclastic activity and bone resorption, there has been some success with the use of antiresportive therapies, such as bisphosphonates and calcitonin, which reduce bone turnover and inhibit bone resorption. 10,19 Calcitonin Calcitonin may impact bone resorption at the cellular level. 19 Bem et al in 2006 revealed that intranasal calcitonin (200 U daily) with calcium supplementations significantly decreased bone turnover compared with calcium supplementation alone. 19 However, Calcitonin did not reveal an effect on skin temperature. Bisphosphonates Frith et al suggested that bisphosphonates may have direct anti-inflammatory properties, inhibit osteoclastic resorption and slow or arrest bone destruction through promotion of macrophage apoptosis. 19 Bisphosphonate effects have been The Northern Ohio Foot & Ankle Foundation Journal reported to last for approximately 6 months. 5 A twelve month duration randomized controlled study by Jude et al in 2001 compared pamidronate with a placebo in the treatment of Charcot. They found symptomatic improvement and reduction in bone turnover markers (urinary deoxypyridinoline and bone-specific alkaline phosphatase) were greater in the bisphosphonate treatment group, but there was no significant difference in reduction in temperature. 20 However, the literature reveals that anti-resporptive therapy doesn t have a significant effect on temperature reduction, has an unknown effect on Charcot resolution, and may increase immobilization duration. 10 Pitocco et al in 2005 revealed that patients treated with zolendronic acid required a longer duration of immobilization compared with a placebo group. 10 This was consistent with a study by Pakarenin et al. in 2011 which reported that bisphosphate use may increase the duration of immobilization. 19 Another study by Pakarenin et al in 2013 reported total immobilization time was 31 weeks in the bisphosphonate group (14 weeks in a cast and 17 weeks in orthosis) versus 23 weeks in the placebo group (11 weeks in a cast and 12 weeks in orthosis). 16 A multicenter observational study in the UK has also revealed that the bisphosphonate treated patients have a longer time until Charcot resolution. 10,19 Contraindications to bisphosphonate use include patients with chronic kidney disease. 19 In addition, the FDA has not approved bisphosphonates for Charcot treatment. As systematic review by Richard et al in 2012 revealed the evidence to support bisphosphonate in the treatment of Charcot use is weak. 10,19 They reviewed 10 studies, 3 were randomized, and all patients were appropriately immobilized. 19 They found that bisphosphonates significantly reduced skin temperature and bone turnover markers compared with placebo. 19 However, the reduction in skin temperature was transient and the bone turner marker most consistently reduced in serum was the (bonespecific) ALP level; a marker of osteoblastic rather
7 than osteoclastic activity). 19 One reviewed study by Anderson et al reported that 60% of the patients treated with pamidronate had transient fever, suggesting a possible pro-inflammatory effect. 19 Bisphosphonates were shown to not shorten the duration of immobilization and may lengthen the resolution phase of the disease. 19 Human Parathyroid Hormone Human parathyroid hormone (teriparatide) is an anabolic agent which may be used to improve bone remodeling. 10 Anabolic agents shorten duration and improve fracture healing. 10 Brosky et al in 2005 reported that teriparatide results in more rapid fracture consolidation, edema control, temperature stabilization, and return to weight-bearing. 10 There is currently a double blind, randomized control study being undertaken on human parathyroid hormone s effect on fracture healing in acute Charcot. 10 Bone Stimulation There is limited evidence for the use of external bone stimulators in the treatment of Charcot. 5 Studies only support its use as an adjunct post-surgical treatment. 5 Conclusion The gold standard of therapy is to offload the acute Charcot foot. The literature trend is to allow full weight-bearing in a TCC for forefoot or midfoot Charcot and restrict to non-weight-bearing in a device for rearfoot Charcot. The contralateral foot is placed in an orthosis or offloading device to avoid bilateral Charcot development. Care and skill are required for TCC application to avoid iatrogenic complications. Weekly to bi-weekly cast changes are recommended, casting duration is guided by clinical measures, and frequent monitoring is required. Also, pharmacological management of acute Charcot is currently unsupported. References 1. Eichenholtz SN: Charcot Joints, Charles C Thomas. Springfield IL, 1966 Nicolosi 2. De Souza LJ. Charcot Arthropathy and Immobilization in a Weight-Bearing Total Contact Cast. J Bone Joint Surg Am : Pinzur MS, Lio T, Posner M. Treatment of Eichenholtz Stage I Charcot Foot Arthropathy with a Weightbearing Total Contact Cast. Foot Ankle Int : Boulton AJM. The Diabetic Foot An Update. Foot and Ankle Surgery : Varma AK. Charcot Neuroarthropathy of the Foot and Ankle: A Review. The Journal of Foot & Ankle Surgery : Baglioni P, Malik M, Okosieme OE. Acute Charcot Foot. BMJ 2012; 344:e Hartsell HD, Fellner C, Saltzman CL. Pneumatic bracing and total contact casting have equivocal effects on plantar pressure relief. Foot Ankle Int Jun;22(6): Botek G, Owings T, Suba J. Evaluating Iatrogenic Complications of the Total Contact Cast: A 6 Year Retrospective Review at CCF Working Paper. 9. Myersoon M, Papa J, Eaton K, Wilson K. The Total Contact Cast for Management of Neuropathic Plantar Ulcerations of the Foot. The Journal of Bone and Joint Surgery (2): Petrova NL, Edmonds ME. Medical Management of Charcot Arthropathy. Diabetes, Obesity and Metabolism : Petrova NL, Edmonds ME. Charcot neuroosteoarthropathy-current standards. Diabetes Metab Res Rev (Suppl 1): S Miller SD. Careful patient management dictates Charcot outcomes. Biomechanics : Milne TE, Rogers JR, Kinnear EM, Martin HV, Lazzarini PA. Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro- Arthropathy: a systematic review. Journal of Foot and Ankle Research : Christensen TM, Gade-Rasmussen B, Pedersen LW, Hommel E, Holstein PE, Svendsen OL. Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker. Journal of Diabetes and Its Complications : Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, 3 AJ, Harkless LB. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care (6): Pakarinen TK, Laine HJ, Mäenpää H, Kähönen M, Mattila P, Lahtela J. Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: A prospective randomized trial. Foot and Ankle Surgery : Guyton GP. An Analysis of Iatrogenic Complications from the Total Contact Cast. Foot Ankle Int : Trepman E. Donnelly P. Patellar Tendon-Bracing, Patten- Bottom Caliper Suspension Orthosis in Active Charcot Arthropathy: Crutch-Free Ambulation with No Weight Bear in the Foot. Foot & Ankle International (4):
8 The Northern Ohio Foot & Ankle Foundation Journal 19. Richard JL, Almasri M, Schuldiner S. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia : Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, 3 AJ. Bisphosphonates in the treatment of Charcot neuroparthropathy: a double blind randomized controlled trial. Diabetologia (11): Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Rep Reg. 2004;12: Malhotra S, Bello E, Kominsky S. Diabetic Foot Ulcerations: Biomechanics, Charcot Foot, and Total Contact Cast. Seminars in Vascular Surgery (22): Najafi B, Wrobel JS, Grewal G, Menzies RA, Talal TK, Zirie M, 14 DG. Plantar Temperature Response to Walking in Diabetes with and without Acute Charcot: The Charcot Activity Response Test. Journal of Aging Research O'Meara, S., NA Cullum, and EA Nelson. "Compression for venous leg ulcers." Cochrane Database, Web. 17 Aug <
Diabetic Neuropathic Arthropathy (Charcot) Kiwon Young M.D. ( 양기원 ) Eulji Hospital Dept of Orthopaedic Foot & Ankle Clinic Seoul, KOREA
Diabetic Neuropathic Arthropathy (Charcot) Kiwon Young M.D. ( 양기원 ) Eulji Hospital Dept of Orthopaedic Foot & Ankle Clinic Seoul, KOREA Charcot 1. What is it? (definition) & Who gets it? (epidemiology
More informationProtected Weight Bearing During Treatment of Acute Charcot Neuroarthropathy: A case series
The Foot and Ankle Online Journal Official publication of the International Foot & Ankle Foundation Protected Weight Bearing During Treatment of Acute Charcot Neuroarthropathy: A case series by Jeremy
More informationCharcot Arthropathy of the Foot & Ankle. MTAPA Annual Meeting June 2018 Emily Harnden, MD
Charcot Arthropathy of the Foot & Ankle MTAPA Annual Meeting June 2018 Emily Harnden, MD Background Disclosures None Learning Objectives Define the disease Recognize presenting signs/symptoms for proper
More informationThe Great Debate: Offloading Diabetic Foot Ulcers: TCC vs. CAM Walkers Gregory A Bohn, MD MAPWCA, ABPM/UHMS
The Great Debate: Offloading Diabetic Foot Ulcers: TCC vs. CAM Walkers Gregory A Bohn, MD MAPWCA, ABPM/UHMS Department of Surgery Central Michigan School of Medicine Tawas, Michigan Disclosures Medical/Scientific
More informationCHARCOT FOOT. What Should we Know?? I Wayan Subawa. Orthopaedi & Traumatology Subdivision Udayana University Sanglah General Hospital, Denpasar-Bali
CHARCOT FOOT What Should we Know?? I Wayan Subawa Orthopaedi & Traumatology Subdivision Udayana University Sanglah General Hospital, Denpasar-Bali INTRODUCTION Peripheral Neuropathy The most insidious
More informationWorking Under Pressure is Not Always. a Good Thing. Kathya M. Zinszer, DPM, MPH, MAPWCA. Geisinger Hospital System Orthopedics Department Danville, PA
Working Under Pressure is Not Always a Good Thing Kathya M. Zinszer, DPM, MPH, MAPWCA Geisinger Hospital System Orthopedics Department Danville, PA Disclosures No relevant financial relationships to disclose.
More informationOff Loading, TCC, Shoe 을지의대을지병원 족부정형외과 이경태
Off Loading, TCC, Shoe 을지의대을지병원 족부정형외과 이경태 DMF Protocol VIPS approach V : Vascular I : infection P : Pressure off S : specific wound care Ulcer/Pressure off& Biomechanics PVD vs Peripheral neuropathy NP
More informationThe Charcot Foot. Lee C. Rogers, DPM a,b, *, Robert G. Frykberg, DPM, MPH c
The Charcot Foot Lee C. Rogers, DPM a,b, *, Robert G. Frykberg, DPM, MPH c KEYWORDS Charcot foot Neuroarthropathy Joints Soft tissues KEY POINTS Charcot foot is primarily a clinical diagnosis at its earliest
More informationDiabetic charcot neuroarthropathy: prevalence, demographics and outcome in a regional referral centre
Ir J Med Sci (2017) 186:151 156 DOI 10.1007/s11845-016-1508-5 ORIGINAL ARTICLE Diabetic charcot neuroarthropathy: prevalence, demographics and outcome in a regional referral centre A. O Loughlin 1 E. Kellegher
More informationUnusual fracture combination with Charcot arthropathy and juvenile-onset diabetes
Injury Extra (2008) 39, 291 295 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/inext CASE REPORT Unusual fracture combination with Charcot arthropathy and juvenile-onset diabetes
More informationSurgical Off-loading. Reiber et al Goals of Diabetic Foot Surgery 4/28/2012. The most common causal pathway to a diabetic foot ulceration
Reiber et al. 1999 Surgical Off-loading The most common causal pathway to a diabetic foot ulceration Alex Reyzelman DPM Associate Professor California School of Podiatric Medicine at Samuel Merritt University
More informationUsing the IWGDF Guidelines for Off-Loading. the Diabetic Foot. Here are some ways to increase clinical outcomes.
Using the IWGDF Guidelines for Off-Loading the Diabetic Foot Here are some ways to increase clinical outcomes. By James McGuire, DPM and Sokieu Mach, B.S. transferring weight stress to the lower leg and
More informationConservative Management to Restore and Maintain Function in Limb Preservation Patients
Conservative Management to Restore and Maintain Function in Limb Preservation Patients Tyson Green, DPM Department Chair Imperial Health Center for Orthopaedics Lake Charles, LA Founder & Medical Director
More informationJonathan Brown Assignment 2 November 11, 2010
1 Jonathan Brown Assignment 2 November 11, 2010 2 The Effectiveness of Removable Walking Casts and Total Contact Casts in Decreasing Healing Times of Diabetic Foot Ulcers Prepared by: jonathan.brown@gbcpando.com
More informationIntroduction. Epidemiology Pathophysiology Classification Treatment
Diabetic Foot Introduction Epidemiology Pathophysiology Classification Treatment Epidemiology DM largest cause of neuropathy in N.A. 1 million DM patients in Canada Half don t know Foot ulcerations is
More informationJack W. Hutter DPM, FACFAS, C.ped
Jack W. Hutter DPM, FACFAS, C.ped First Described in 1883 as osteoarthropathy seen in cases of syphilis The typical presentation of the rocker bottom foot As imaging techniques improved the extent of severity
More informationCharcot Foot: Potential Pearls from Parkland
Charcot Foot: Potential Pearls from Parkland Javier La Fontaine, D.P.M., M.S. Professor Department of Plastic Surgery UT Southwestern Medical Center Dallas, Texas Objectives To share the experience from
More informationDiabetic Foot Ulcer. A Complete Solution. Therapy Approach with Adapted Products
Diabetic Foot Ulcer A Complete Solution Therapy Approach with Adapted Products A Complete Solution for Diabetic Foot Ulcers This booklet focuses on the recommended treatment of diabetic foot ulcers. Diabetes
More informationClinical Guideline for: Diagnosis and Management of Charcot Foot
Clinical Guideline for: Diagnosis and Management of Charcot Foot SUMMARY This guideline outlines the clinical features of Charcot foot (Charcot Neuroarthropathy). It also explains the process of diagnosis
More informationCharcot s Neuroarthropathy: A Case Report and Review of Literature
1 Kotwal N et al. Charcot s Neuroarthropathy: A Case Report and Review of Literature Vimal Upreti *, Narendra Kotwal *, Vishesh Verma *, Shrikant Somani *, Yogesh Kumar * Abstract Charcot s neuroarthropathy
More informationThe Charcot Foot. Brian J Burgess, DPM, AACFAS Hinsdale Orthopaedic Assoc. Midwest Podiatry Conference April 19, 2013
The Charcot Foot Brian J Burgess, DPM, AACFAS Hinsdale Orthopaedic Assoc. Midwest Podiatry Conference April 19, 2013 Brian J Burgess, DPM, AACFAS Associate of Hinsdale Orthopaedics. Doctor of Podiatric
More informationDiabetic Foot Complications
Diabetic Foot Complications Podiatry Specialty Clinic YKHC Bethel, Alaska August 1-3, 2017 Charles C. Edwards, DPM Alaska Native Tribal Health Consortium Peripheral Neuropathy Diabetic Peripheral Neuropathy
More informationHelen Gelly, MD, FUHM, FCCWS
Helen Gelly, MD, FUHM, FCCWS Diabetes mellitus is a major risk factor that impairs wound healing, making foot wounds one of the major problems of diabetes. Over 60% of lower limb amputations in the US
More informationUse of Pressure Offloading Devices in Diabetic Foot Ulcers: Do We Practice What We Preach?
Diabetes Care Publish Ahead of Print, published online August 11, 2008 Use of : Do We Practice What We Preach? Stephanie C. Wu, DPM, MSc 2 Jeffrey L. Jensen, DPM 1,3 Anna K. Weber, DPM 3,4 Daniel E. Robinson,
More informationResection Arthroplasty for Limb Salvage of the Unreconstructable Charcot Foot & Ankle
Resection Arthroplasty for Limb Salvage of the Unreconstructable Charcot Foot & Ankle Michael Greaser MD and James Brodsky MD Baylor University Medical Center Dallas, TX Resection Arthroplasty for Limb
More informationAetiology Macroangiopathy occurs mainly distally ie Popliteal artery There is arterial wall calcification Microangiopathy is less common
DIABETIC FOOT Facts 5% of the population is diabetic 12% of diabetic admissions are with foot problems 1/3rd of diabetic foot ulcerations are neuropathic, 1/3rd are ischaemic and 1/3 are of a mixed in
More informationAssessment of Removable Short Total Contact Cast in Comparison to Irremovable Total Contact Cast in the Management of Diabetic Neuropathic Ulcers
Med. J. Cairo Univ., Vol. 81, No. 1, June: 417-422, 2013 www.medicaljournalofcairouniversity.net Assessment of Removable Short Total Contact Cast in Comparison to Irremovable Total Contact Cast in the
More informationFull Title: 5 year retrospective follow-up of new cases of Charcot neuroarthropathy a single centre experience
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 Full Title: 5 year retrospective follow-up of new cases of Charcot neuroarthropathy
More informationDisclosures CONSULTANT WRIGHT MEDICAL CONSULTANT ORTHO FIX
Disclosures CONSULTANT WRIGHT MEDICAL CONSULTANT ORTHO FIX Overview Radiographic Pattern Histopathology Pathways: RANKL/OPG AGE/RAGE Treatment based on Evidence Radiographic Pattern Pattern of Diabetic
More informationTotal Contact Cast System
Total Contact Cast System Instructions for Use Products Included in Cutimed Off-Loader Select kit Qty Cutimed Cavity Sterile 1 ea. Cutisorb Cotton Gauze 2" x 2" 4 ea. Delta-Lite Conformable Fiberglass
More informationPreventing Foot Ulcers in the Neuropathic Diabetic Foot. Glossary of Terms
Preventing Foot Ulcers in the Neuropathic Diabetic Foot Warren Woods, Certified Orthotist, Health Sciences Centre, Rehabilitation Engineering Department What you need to know Glossary of Terms Neuropathic
More informationDiabetic Foot Ulcer Treatment and Prevention
Diabetic Foot Ulcer Treatment and Prevention Alexander Reyzelman DPM, FACFAS Associate Professor California School of Podiatric Medicine at Samuel Merritt University Diabetic Foot Ulcers One of the most
More informationProject I - Background Worksheet. Team Members: Kira Brown, Paige Fallu. Clinical problem Diabetic Foot Ulcers
Project I - Background Worksheet Team Members: Kira Brown, Paige Fallu Clinical problem Diabetic Foot Ulcers 1) Strategic Focus based on the Strategic focus powerpoint presentation and readings a. Team
More informationIncreased pressures at
Surgical Off-loading of Plantar Hallux Ulcerations These approaches can be used to treat DFUs. By Adam R. Johnson, DPM Increased pressures at the plantar aspect of the hallux leading to chronic hyperkeratosis
More informationPrevalence of Symptomatic Venous Thrombo-Embolism in Patients with Total Contact Cast for Diabetic foot Complications A Retrospective Case Series.
Prevalence of Symptomatic Venous Thrombo-Embolism in Patients with Total Contact Cast for Diabetic foot Complications A Retrospective Case Series. Dr R King, Miss GE Jackson, Mr SR Platt Wirral University
More informationOrthopaedic Surgery and the Diabetic Charcot Foot
Orthopaedic Surgery and the Diabetic Charcot Foot Wei Shen, MD, PhD, Dane Wukich, MD* KEYWORDS Diabetes Foot Charcot Orthopaedic surgery KEY POINTS Due to the systemic manifestations of diabetes mellitus
More informationCare of the Diabetic Patient
Care of the Diabetic Patient Aarti Deshpande, CPO Clinic Manager Zuckerberg San Francisco General Department of Orthopaedic Surgery University of California, San Francisco March 16, 2017 Diabetes Diabetes
More informationAnchoring Bias in the Case of Charcot s Foot. By: Vadieh Hamidi. Home for the Summer Program July to August Portage La Prairie, Manitoba
Anchoring Bias in the Case of Charcot s Foot By: Vadieh Hamidi Home for the Summer Program July to August 2018 Portage La Prairie, Manitoba Supervisor: Dr. Brett Finney 1 Abstract During my six-week Home
More informationLong-term follow-up of joint stabilization procedures in the treatment of fixed deformities of feet in leprosy
Lepr Rev (1996) 67, 126-134 Long-term follow-up of joint stabilization procedures in the treatment of fixed deformities of feet in leprosy M. EBENEZER, S. PARTHEEBARAJAN & S. SOLOMON Branch of Surgery
More informationDiabetes Mellitus and the Associated Complications
Understanding and the complications relating to the disease can assist the fitter to better serve patients. and the Associated Complications Released January, 2011 Total: 25.8 million people, or 8.3% of
More informationDefinitions and criteria
Several disciplines are involved in the management of diabetic foot disease and having a common vocabulary is essential for clear communication. Thus, based on a review of the literature, the IWGDF has
More information10/19/2017. Shawn M Sanicola DPM, FACFAS Foot And Ankle Associates of WI. Consultant with J&J-Depuy-Synthesis
Shawn M Sanicola DPM, FACFAS Foot And Ankle Associates of WI Consultant with J&J-Depuy-Synthesis Understand the systemic effects of diabetes on the lower extremity The significance of structural and biomechanical
More informationDiabetic Foot Ulcers. Care for Patients in All Settings
Diabetic Foot Ulcers Care for Patients in All Settings Summary This quality standard focuses on care for people who have developed or are at risk of developing a diabetic foot ulcer. The scope of the standard
More informationYour Orthotics service is changing
Your Orthotics service is changing Important information for service users on changes effective from July 2015 Why is the service changing? As demand for the Orthotics service increases, Livewell Southwest
More informationPage th Annual Clinical Symposium on Advances in Skin and Wound Care Washington DC, Total Contact Cast: Is it Really the Gold Standard?
26 th Annual Clinical Symposium on Advances in Skin and Wound Care Washington DC, 2011 James McGuire DPM, PT, CPed, FAPWCA Certified in Wound Care by the Council for Medical Education and Testing, CMET
More informationFinancial Disclosure. Turf Toe
Seth O Brien, CP, LP Financial Disclosure Mr. Seth O'Brien has no relevant financial relationships with commercial interests to disclose. Turf Toe Common in athletes playing on firm, artificial turf Forceful
More informationAWMA MODULE ACCREDITATION. Module Five: The High Risk Foot (Including the Diabetic Foot)
AWMA MODULE ACCREDITATION Module Five: The High Risk Foot (Including the Diabetic Foot) Introduction - The Australian Wound Management Association Education & Professional Development Sub Committee-(AWMA
More informationManagement of Charcot Arthropathy
Review Article Management of Charcot Arthropathy Shahnooshi Javad F* Department of Pharmacy Practice, Krupandhi College of Pharmacy, Chikkabellandur Village, Varthur Hobli, Bangalore 560035, India. J.
More informationDeveloping an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review
Milne et al. Journal of Foot and Ankle Research 2013, 6:30 JOURNAL OF FOOT AND ANKLE RESEARCH REVIEW Open Access Developing an evidence-based clinical pathway for the assessment, diagnosis and management
More informationIndex. Foot Ankle Clin N Am 11 (2006) Note: Page numbers of article titles are in boldface type.
Foot Ankle Clin N Am 11 (2006) 865 869 Index Note: Page numbers of article titles are in boldface type. A Alpha-lipoic acid, in diabetic neuropathy, 764 Amputation(s), lower-extremity, in diabetes, 791
More informationYour Orthotics service is changing
Your Orthotics service is changing Important for referrers on changes effective from January 2015 Why is the service changing? As demand for the orthotics service increases and budgets remain relatively
More informationDavid G. Armstrong, DPM, MD, PhD 1 ; Adam L. Isaac, DPM 2 ; Nicholas J. Bevilacqua, DPM 3 ; Stephanie C. Wu, DPM, MS 4
REVIEW WOUNDS 2014;26(1):13-20 From the 1 University of Arizona College of Medicine, Tucson, AZ; 2 Mid-Atlantic Permanente Medical Group, Rockville, MD; 3 North Jersey Orthopaedic Specialists, Teaneck,
More information1 of :28
1 of 15 14-3-2013 22:28 Footwear and off-loading for the diabetic foot -an evidence based guideline- Prepared by the IWGDF working group on Footwear and off-loading Content Chapters: 1. Introduction 2.
More informationAppendix H: Description of Foot Deformities
Appendix H: Description of Foot Deformities The following table provides the description for several foot deformities: hammer toe, claw toe, hallux deformity, pes planus, pes cavus and charcot arthropathy.
More informationORTHOTI MANAGEMENT OF DIABETIC FEET. Tarun Kumar Kulshreshtha, Clinical Prosthetist & Orthotist, Guest Facutly, University of Delhi, New Delhi, India
ORTHOTI MANAGEMENT OF DIABETIC FEET Tarun Kumar Kulshreshtha, Clinical Prosthetist & Orthotist, Guest Facutly, University of Delhi, New Delhi, India INTRODUCTION Diabetic Melitus is a group of metabolic
More informationA Patient s Guide to Adult-Acquired Flatfoot Deformity
A Patient s Guide to Adult-Acquired Flatfoot Deformity Glendale Adventist Medical Center 1509 Wilson Terrace Glendale, CA 91206 Phone: (818) 409-8000 DISCLAIMER: The information in this booklet is compiled
More informationPredicting & Preventing Diabetic Ulcerations Utilizing Computerized Pressure Gait Analysis
Predicting & Preventing Diabetic Ulcerations Utilizing Computerized Pressure Gait Analysis Jeffrey A. Ross, DPM, MD, FACFAS, FAPWCA Associate Clinical Professor Baylor College of Medicine Houston, Texas
More informationCommon Foot and Ankle Conditions: How Can You Find Relief?
Common Foot and Ankle Conditions: How Can You Find Relief? Your Feet and Ankles are Workhorses They bear a lot of weight They perform various movements Common Conditions That Cause Foot/Ankle Pain Plantar
More informationCase Study: Christopher
Case Study: Christopher Conditions Treated Anterior Knee Pain, Severe Crouch Gait, & Hip Flexion Contracture Age Range During Treatment 23 Years to 24 Years David S. Feldman, MD Chief of Pediatric Orthopedic
More informationA Prospective Study of Calcaneal Bone Mineral Density in Acute Charcot Osteoarthropathy
Diabetes Care Publish Ahead of Print, published online July 13, 2010 Fall of BMD in Charcot osteoarthropathy A Prospective Study of Calcaneal Bone Mineral Density in Acute Charcot Osteoarthropathy Short
More informationThe Georgetown Team Approach to Diabetic Limb Salvage: 2013
The Georgetown Team Approach to Diabetic Limb Salvage: 2013 John S. Steinberg, DPM FACFAS Associate Professor, Department of Plastic Surgery Georgetown University School of Medicine Disclosures: None Need
More informationDetermine if a non-removable offloading device is appropriate
Developed in collaboration with the Wound Care Champions, Wound Care Specialists, Enterostomal Nurses, and South West Regional Wound Care Program (SWRWCP) members from Long Term Care Homes, Hospitals,
More informationCalcaneus (Heel Bone) Fractures
Page 1 of 8 Calcaneus (Heel Bone) Fractures A fracture of the calcaneus, or heel bone, can be a painful and disabling injury. This type of fracture commonly occurs during a high-energy event such as a
More informationI also call this lecture
I also call this lecture GO BUCKS!!! My Background Cornerstone University Grand Rapids, MI Kent State University College of Podiatric Medicine (OCPM) Florida Hospital East Orlando 3 year surgical residency
More informationConcepts of Total Contact Cast(TCC) Negative Pressure Wound Therapy(NPWT)
Concepts of Total Contact Cast(TCC) & Negative Pressure Wound Therapy(NPWT) Chungnam National University Hospital Orthopaedic Surgery Chan Kang Total Contact Cast TTC on DM foot ulcer Risk classification
More information2008 American Medical Association and National Committee for Quality Assurance. All Rights Reserved. CPT Copyright 2007 American Medical Association
Chronic Wound Care ASPS #1: Use of wound surface culture technique in patients with chronic skin ulcers (overuse measure) This measure may be used as an Accountability measure Clinical Performance Measure
More informationCustom-made total contact insoles and prefabricated functional diabetic insoles: A case report
Custom-made total contact insoles and prefabricated functional diabetic insoles: A case report Joanne Paton, Elizabeth Stenhouse, Ray Jones, Graham Bruce Insoles are commonly prescribed to offload the
More informationAMERICAN RED CROSS FIRST AID RESPONDING TO EMERGENCIES FOURTH EDITION Copyright 2006 by The American National Red Cross All rights reserved.
Musculoskeletal injuries are most commonly caused by Mechanical forms of energy. Chemicals. Electrical energy. Heat Mechanical energy produces direct, indirect, twisting and contracting forces. Can be
More informationIndian Journal of Basic & Applied Medical Research; December 2011: Issue-1, Vol.-1, P
Original article: Analysis of the Risk Factors, Presentation and Predictors of Outcome in Patients Presenting with Diabetic Foot Ulcers at Tertiary Care Hospital in Karnataka Sarita Kanth Associate Professor,
More informationVASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS
VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS KANSAS ASSOCIATION OF OSTEOPATHIC MEDICINE ANNUAL CME CONVENTION APRIL 13, 2018 THREE
More informationQuicker application Great comfort. TCC wound healing rate 1,2. Advancing the Gold Standard of Care. ESSENTIAL TO HEALTH
Quicker application Great comfort GOLD STANDARD OF CARE TCC wound healing rate 1,2 Advancing the Gold Standard of Care. ESSENTIAL TO HEALTH Why risk any other treatment method? Potential consequences for
More informationFoot and Ankle Pearls
Foot and Ankle Pearls Steve Milner Consultant Trauma, Orthopaedic and Foot & Ankle Surgeon Royal Derby Hospital Foot and Ankle PERILS Steve Milner Consultant Trauma, Orthopaedic and Foot & Ankle Surgeon
More informationOff-loading a wound is key to the beginning of the healing process
Off-loading a wound is key to the beginning of the healing process DARCO provides surgical, trauma and wound care solutions to the global foot and ankle community Now available in India: Worldwide proven
More informationNonremovable, Windowed, Fiberglass Cast Boot in the Treatment of Diabetic Plantar Ulcers
Emerging Treatments and Technologies O R I G I N A L A R T I C L E Nonremovable, Windowed, Fiberglass Cast Boot in the Treatment of Diabetic Plantar Ulcers Efficacy, safety, and compliance GEORGES HA VAN,
More informationMr. Siva Chandrasekaran Orthopaedic Surgeon MBBS MSpMed MPhil (surg) FRACS
Bunion Surgery Most people with bunions find pain relief with simple treatments to reduce pressure on the big toe, such as wearing wider shoes or using pads in their shoes. However, if these measures do
More informationClinician s Guide to Prevention and Treatment of Osteoporosis
Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening
More informationDiabetic foot: primary prevention and the patient in remission
Chapter 35 Diabetic foot: primary prevention and the patient in remission Pooja Rajguru, John Miller, Klaas Postema and David G. Armstrong Key message Shoes are not primarily suitable for offloading in
More informationCharcot Neuroarthropathy
CLINICAL VIGNETTE Charcot Neuroarthropathy Spencer R. Adams, MD, Roger M. Lee, MD and Matthew Leibowitz, MD Acute Charcot foot (Charcot neuroarthropathy (CN)) is an often overlooked complication in diabetic
More informationBarriers Between Injury and Returnto-Work. Lower Extremity. Why the Extreme Variability
Barriers Between Injury and Returnto-Work in the Lower Extremity Why the Extreme Variability Barriers to Diagnosis Failure or delay in reporting injury Employee expectations: Not really a serious injury
More informationIWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes
DIABETES/METABOLISM RESEARCH AND REVIEWS Diabetes Metab Res Rev 2016; 32(Suppl. 1): 25 36. Published online in Wiley Online Library (wileyonlinelibrary.com).2697 SUPPLEMENT ARTICLE IWGDF guidance on footwear
More information.org. Tibia (Shinbone) Shaft Fractures. Anatomy. Types of Tibial Shaft Fractures
Tibia (Shinbone) Shaft Fractures Page ( 1 ) The tibia, or shinbone, is the most common fractured long bone in your body. The long bones include the femur, humerus, tibia, and fibula. A tibial shaft fracture
More informationBunion (hallux valgus deformity) surgery
Bunion (hallux valgus deformity) surgery Bunion surgery is generally reserved for bunions that are severe and impacting on function. There most frequent surgical procedure used involves a medial incision
More informationSUBTALAR ARTHROEREISIS IN THE OLDER PATIENT
C H A P T E R 1 7 SUBTALAR ARTHROEREISIS IN THE OLDER PATIENT William D. Fishco, DPM, MS INTRODUCTION Arthroereisis is a surgical procedure designed to limit the motion of a joint. Subtalar joint arthroereisis
More informationMinimally Invasive Closing Wedge Osteotomy for Charcot Correction
AOFAS 2015 Long Beach, California DISCLOSURES* Minimally Invasive Closing Wedge Osteotomy for Charcot Correction Vernois* Miss Ros Miller FRCS Tr&Orth Consultant Orthopaedic Surgeon Hairmyres Hospital,
More informationThe Diabetic Foot. Michael Anthony, DPM. 422 million diabetic million % adult population 90% Type II
The Diabetic Foot Michael Anthony, DPM Assistant Professor - Clinical Department of Orthopaedics The Ohio State University Wexner Medical Center Prevalence of Diabetes 422 million diabetic 2016 382 million
More informationThe Diabetic Foot. Prevalence of Diabetes United States. Prevalence of Diabetes
The Diabetic Foot Prevalence of Diabetes Michael Anthony, DPM Assistant Professor - Clinical Department of Orthopaedics The Ohio State University Wexner Medical Center 422 million diabetic 2016 382 million
More informationWHAT IS THIS CONDITION? COMMON CAUSES:
Mr Laurence James BSc MBBS MRCS(Eng) FRCS(Tr&Orth) Consultant Orthopaedic Surgeon Foot, Ankle and Sports Injuries WHAT IS THIS CONDITION? The posterior tibial tendon is an important structure that is normally
More informationCharcot neuroarthropathy (CN) was first described
æreview ARTICLE Conservative and surgical treatment of the chronic Charcot foot and ankle Mehmet Fatih Güven, MD, Atakan Karabiber, MD, Gökhan Kaynak, MD and Tahir Öğüt, MD* Cerrahpasa Faculty of Medicine,
More informationLesser Toe Correction
Richard M. Marks, MD Professor and Director Division of Foot and Ankle Department of Orthopaedic Surgery Medical College of Wisconsin Explanation: Lesser Toe Correction Lesser toe deformities are classified
More informationMonitoring Prevent. Can Temperature. DFUs
Can Temperature Monitoring Prevent DFUs Alexander Reyzelman DPM Associate Professor, California School of Podiatric Medicine at Samuel Merritt University Oakland, CA Co-Director, UCSF Center for Limb Preservation
More informationKira Brown & Paige Fallu December 12th, 2017 BME 4013 ROAD: Removable Offloading Adjustable Device
Kira Brown & Paige Fallu December 12th, 2017 BME 4013 ROAD: Removable Offloading Adjustable Device Abstract Diabetes is a costly and devastating disease that affected 382 million people worldwide and cost
More informationForefoot Procedures to Heal and Prevent Recurrence. Watermark. Diabetic Foot Update 2015 San Antonio, Texas
Forefoot Procedures to Heal and Prevent Recurrence Diabetic Foot Update 2015 San Antonio, Texas J. Randolph Clements, DPM Assistant Professor of Orthopaedics Virginia Tech- Carilion School of Medicine
More informationReconstructing Limb Deformities using the VCAM TM External Fixator: A series of 3 cases
The Foot and nkle Online Journal Open ccess Publishing Reconstructing Limb Deformities using the VCM TM External Fixator: series of 3 cases by Michael P. DellaCorte, DPM, FCFS 1, Panagiotis Panagakos,
More informationPeripheral Neuropathy
Peripheral Neuropathy Neuropathy affects 30-50% of patient population with diabetes and this prevalence tends to increase proportionally with duration of diabetes and dependant on control. Often presents
More informationPRESCRIPTION FOOTWEAR
PRESCRIPTION FOOTWEAR Standards of Practice for Chiropodists and Podiatrists I. Introduction Prescription footwear is an integral part of patient care for the management of lower extremity pathology and
More informationFoot & Ankle Products with Clinical Data
Foot & Ankle Products with Clinical Data Podalux post-op shoe Podalux Developers Dr Determe Toulouse Dr Cermolacci - Marseille Dr Coillard Lyon Dr Laffenetre - Bordeaux Podalux Indications Post-operative
More informationAnthony J. Cavallo, DPM Sentara Podiatry Specialists 4/27/2018. Lose a toe, Save a Limb: The Value of Complex Foot Reconstructions
Anthony J. Cavallo, DPM Sentara Podiatry Specialists 4/27/2018 Lose a toe, Save a Limb: The Value of Complex Foot Reconstructions Objectives Review the morbidity and mortality associated with amputation
More informationManagement Of The Diabetic foot
Management Of The Diabetic foot Aims, Pathways, Treatments Nikki Coates 12/1/18 Diabetic foot pathology Neuropathy Foot deformity Vascular disease Sensory neuropathy Limited Joint Mobility Smoking Autonomic
More informationPredictive Value of Foot Pressure Assessment as Part of a Population- Based Diabetes Disease Management Program
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Predictive Value of Foot Pressure Assessment as Part of a Population- Based Diabetes Disease Management Program LAWRENCE
More informationTherapeutic Shoes for Diabetics
Last Review Date: August 11, 2017 Number: MG.MM.DM.03bC8v2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
More information